OREX

Orexigen Therapeutics, Inc. News Headlines

$5.3
*  
0.08
 negative 
1.49%
Get OREX Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

With Share Offering Registration And Trial Enrollment Complete, Time To Buy MannKind
10/12/2012 5:43:00 PM - Seeking Alpha

Can Orexigan Benefit From Possible FDA Changes In Approval?
10/11/2012 6:39:00 PM - Seeking Alpha

Weight Loss Stocks In Action
9/25/2012 11:22:00 AM - Seeking Alpha

With Arena, Patience Is A Virtue
9/24/2012 5:01:00 PM - Seeking Alpha

The right data is key to spotting trends
9/21/2012 10:34:03 AM - optionMONSTER

Vivus Launches Obesity Drug Qsymia - Analyst Blog
9/20/2012 6:22:01 PM - Zacks.com

Vivus: Primed To Hit $30
9/20/2012 6:31:00 AM - Seeking Alpha

Obesity Drug Stocks React To New Data
9/19/2012 8:36:00 PM - Seeking Alpha

Vivus Is Cheaper Than Arena
9/14/2012 12:07:00 PM - Seeking Alpha

Arena Pharmaceuticals Price Target Sets Low Bar
9/7/2012 2:55:00 PM - Seeking Alpha

Today's Market News To Trade On: 5 Stocks Moving On News
9/7/2012 9:03:00 AM - Seeking Alpha

Buy or Sell? Wednesday's Winners: GWRE, OREX
9/5/2012 9:30:00 AM - David Sterman

Investing in Biotech Stocks? The Journey to Profits Requires a Good GPS
8/31/2012 12:21:37 PM - OptionsANIMAL

Arena Cuts Loss, Sales Climb - Analyst Blog
8/14/2012 8:21:26 AM - Zacks.com

Glory for Vivus After Arena - Analyst Blog
7/18/2012 2:09:09 PM - Zacks.com

Pre-Market Most Active for Jul 18, 2012 : BAC, VVUS, SAN, AGNC, ARNA, BHP, TOT, OREX, ERIC, QQQ, RIO, SBH
7/18/2012 8:39:51 AM - NASDAQ.com News

Pre-Market Most Active for Jul 17, 2012 : QQQ, BAC, S, TOT, SAP, CMA, JNJ, YHOO, FB, OREX, MAT, AAPL
7/17/2012 8:39:56 AM - NASDAQ.com News

Pre-Market Most Active for Jul 16, 2012 : HGSI, C, BAC, PRX, TOT, QQQ, NTT, SIRI, FTE, OREX, ARNA, ASML
7/16/2012 8:39:56 AM - NASDAQ.com News

Weekly CEO Sells Highlight: Orexigen Therapeutics Inc, Gas Natural Inc, The Middleby ...
7/15/2012 11:46:46 PM - GuruFocus

Arena Seeks Approval in Switzerland - Analyst Blog
7/13/2012 12:46:45 PM - Zacks.com

Pre-Market Most Active for Jul 11, 2012 : BZH, UN, QQQ, BAC, BUD, ARNA, CYS, PSEC, UBS, OREX, ERIC, SIRI
7/11/2012 8:39:59 AM - NASDAQ.com News

Weekly CEO Sells Highlight: Gas Natural Inc, Encore Bancshares Inc, Staples Inc, and Orexigen ...
7/8/2012 5:46:14 PM - GuruFocus

Second Time Lucky for Arena's Belviq - Analyst Blog
6/29/2012 10:12:38 AM - Zacks.com

Pre-Market Most Active for Jun 28, 2012 : BAC, BCS, JPM, ARNA, VRTX, NOK, OREX, C, ETP, EBAY, FB, QQQ
6/28/2012 8:39:52 AM - NASDAQ.com News

Zacks' Voice of the People highlights opportunities with Starbucks, Realty Income, Keryx Biopharma, Bon-Ton Stores and Orexigen Therapeutics - Press Releases
4/12/2012 9:10:39 AM - Zacks.com